Structure Therapeutics, Inc. (GPCR)
42.34
+0.81
(+1.95%)
USD |
NASDAQ |
Jun 11, 11:32
Structure Therapeutics Shareholders Equity (Quarterly) : 1.447B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 1.447B |
| December 31, 2025 | 1.516B |
| September 30, 2025 | 770.02M |
| June 30, 2025 | 772.09M |
| March 31, 2025 | 824.65M |
| December 31, 2024 | 864.84M |
| September 30, 2024 | 896.81M |
| June 30, 2024 | 921.06M |
| March 31, 2024 | 429.81M |
| Date | Value |
|---|---|
| December 31, 2023 | 452.97M |
| September 30, 2023 | 192.96M |
| June 30, 2023 | 214.41M |
| March 31, 2023 | 236.35M |
| December 31, 2022 | 84.84M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 102.22M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.20B |
| Novo Nordisk A/S | 31.31B |
| Viking Therapeutics, Inc. | 501.92M |
| Pfizer Inc. | 90.10B |
| Tarsus Pharmaceuticals, Inc. | 348.95M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.508B |
| Total Liabilities (Quarterly) | 61.03M |
| Debt to Equity Ratio | 0.004 |
| Current Ratio | 26.16 |
| Net Debt Paydown Yield | -0.01% |